SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Progyny, Inc. (PGNY) News

Follow Progyny, Inc. (PGNY) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 17 public stories across 8 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol PGNY Asset equity Sector Markets 90 days 13 Last 35.71 Updated Nov 06, 2026, 08:04 AM UTC Open live news feed Open PGNY chart & news
M PGNY Reports Q3 Revenue Growth as Clients and Members Rise EQUITY | Nov 06, 2026, 08:04 AM UTC M Progyny Reports Third-Quarter 2026 Revenue of $341.25M, EPS of $0.32 Progyny said third-quarter revenue and net income increased year over year, citing higher client and covered-life counts. Gross margin improved, while operating expenses declined. EQUITY | Nov 05, 2026, 02:11 PM UTC M Progyny Raises FY2026 Adjusted EPS and Sales Guidance Progyny raised FY2026 adjusted EPS guidance from $2.04-$2.10 to $2.09-$2.13 and sales guidance from $1.360B-$1.385B to $1.365B-$1.385B. The headline lists estimates of $1.28 EPS and $1.373B sales. EARNINGS | Nov 04, 2026, 09:22 PM UTC M Progyny Raises FY2026 GAAP EPS Guidance to $1.30-$1.35 Progyny lifted its FY2026 GAAP EPS guidance from $1.26-$1.32 to $1.30-$1.35, versus a $1.28 estimate. EARNINGS | Nov 04, 2026, 09:22 PM UTC M Progyny Expects Q4 Revenue of $344.7M-$364.7M EQUITY | Nov 04, 2026, 09:13 PM UTC M Progyny Expects Q4 Adjusted EPS of $0.53–$0.58 EARNINGS | Nov 04, 2026, 09:13 PM UTC M Progyny Reports Q3 Revenue of $341.3 Million Q3 revenue was $341.3 million, versus a FactSet estimate of $340.8 million. EQUITY | Nov 04, 2026, 09:05 PM UTC M Progyny Q3 Pretax Profit $36.416 Million EQUITY | Nov 04, 2026, 09:05 PM UTC M Progyny Announces Third-Quarter 2026 Results Progyny reported record third-quarter results for revenue, gross profit, adjusted EBITDA and net income. EQUITY | Nov 04, 2026, 09:05 PM UTC L PGNY: Stable demand, expanding products, and strong cost control support robust growth outlook Seasonal utilization softness was noted but is seen as normal, with stable demand expected for the year. Growth is driven by expanding market acceptance, new risk-based products for smaller employers, and ongoing cost co EQUITY | Sep 08, 2026, 04:49 PM UTC L PGNY cites stable demand and new offerings amid cost pressures PGNY says seasonal utilization softness is expected to be normal, while stable demand should hold for the year. Growth drivers include smaller employers, global markets and new products; capital goes to innovation, M&A a MNA | Sep 08, 2026, 04:20 PM UTC L Citizens raises Progyny price target to $33 from $31 Citizens, via Benzinga, maintained Progyny’s Market Outperform rating and raised its price target to $33.00 per share from $31.00. EQUITY | Sep 08, 2026, 01:46 PM UTC L Progyny to present at Wells Fargo Healthcare Conference Progyny, Inc. said it will present at the Wells Fargo Healthcare Conference. EQUITY | Sep 03, 2026, 03:16 PM UTC L Wells Fargo initiates PGNY at Overweight, $37.00 price target Wells Fargo initiates PGNY with an Overweight rating and a $37.00 price target, according to the report. EQUITY | Aug 20, 2026, 11:56 AM UTC L Progyny Raises FY2026 Adj EPS Guidance from $1.98-$2.09 to $2.04-$2.10 vs $1.29 Est; Lowers FY2026 Sales Guidance from $1.365B-$1.405B to $1 Progyny (NASDAQ: PGNY ) raises FY2026 Adj EPS guidance from $1.98-$2.09 to $2.04-$2.10 vs $1.29 analyst estimate. Lowers FY2026 sales outlook from $1.365 billion-$1.405 billion to $1.360 billion-$1.385 billion vs $1.384 EARNINGS | Aug 06, 2026, 08:02 PM UTC L PGNY downgraded to EW from OW, but raise PT to $34 from $27 @ BARC PGNY downgraded to EW from OW, but raise PT to $34 from $27 @ BARC EQUITY | Jul 28, 2026, 11:41 AM UTC L Top Downgrades: ACI: NEUTRAL @ UBS CAPR: NEUTRAL @ ROTH CAT: HOLD @ Erste CLX: HOLD @ Jefferies EBC: EQUAL WEIGHT @ Stephens INTU: HOLD @ TD Top Downgrades: ACI: NEUTRAL @ UBS CAPR: NEUTRAL @ ROTH CAT: HOLD @ Erste CLX: HOLD @ Jefferies EBC: EQUAL WEIGHT @ Stephens INTU: HOLD @ TD Cowen LAUR: UNDERWEIGHT @ MS LEVI: EQUAL WEIGHT @ WFC MPLT: EQUAL WEIGHT @ MS P EQUITY | Jul 28, 2026, 11:11 AM UTC